• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Pulmonology

Asthma linked to risk of new-onset obstructive sleep apnea

byReshmi MadankumarandPriyanka Vedak
January 14, 2015
in Pulmonology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. A pre-existent asthma diagnosis is a risk factor for developing obstructive sleep apnea (OSA) over a 4-year period.

2. The duration of asthma diagnosis has a dose-dependent relationship on the association between asthma and OSA.

Evidence Rating Level: 2 (Good)       

Study Rundown: Obstructive sleep apnea (OSA) is a major health concern as it has been implicated in numerous comorbidities, including cardiovascular disease, hypertension, diabetes, obesity and depression. Although certain risk factors such as obesity, craniofacial structural issues and alcohol use have been established as risk factors, the causal relationship of asthma to developing OSA has not been well elucidated. Various studies have suggested a reciprocal relationship between asthma and OSA.

This study aimed to prospectively determine whether asthma is a risk factor for development of OSA. It was found that asthma was indeed a risk factor for developing OSA over a 4-year time frame and that the duration of asthma correlated to the relationship between asthma and OSA. Limitations of this study include lack of objective assessments of the asthma diagnosis in participants and inadequate number of participants to determine the risk of asthma with onset of moderate-severe OSA. Future studies can tackle these limitations as well as determine the etiologic relationship of asthma in causing OSA and the value of screening for OSA in patients with asthma.

Click to read the study, published today in JAMA

Relevant Reading: Obstructive Sleep Apnea Syndrome and Asthma: What are the Links?

RELATED REPORTS

Impact of COVID-19 on pediatric asthma-related healthcare utilization in New York City

Sodium-glucose cotransporter 2 inhibitors may reduce incidence of obstructive airway disease

Intranasal corticosteroids no better than saline in treating pediatric sleep-disordered breathing

In-Depth [prospective cohort study]: This study obtained participants from the Wisconsin Sleep Cohort Study (n=547). Asthma diagnosis was determined by self-reported questionnaire. To be included in the analysis, patients had to be determined as OSA-free at baseline, which was defined as an apnea/hypopnea index (AHI) <5 events/hour and no use of continuous or bilevel positive airway pressure on the first 2 polynsomnography studies. Patients who were determined to be OSA-free were observed for development of incident OSA from baseline with polysnomnography at 4-year intervals. In the end, 22 of 81 participants with asthma developed incident OSA in the first 4-year follow-up period compared to 75 of 466 participants without asthma (p=0.02). The relative risk for incident OSA was 1.39 (95%CI, 1.06-1.82) and 2.72 (95%CI, 1.26-5.89) for incident OSA with habitual sleepiness for patients with pre-existing asthma compared to those without asthma. Five-year increments in the duration of asthma diagnosis were associated with a higher risk of incident OSA and OSA with habitual sleepiness.

More from this author: B-blockers linked to improved survival in preserved ejection fraction heart failure, Prophylactic implantable cardioverter-defibrillators may decrease mortality in left ventricular dysfunction, The VIDA trial: Vitamin D3 does not improve outcomes in asthma patients, No survival benefit with everolimus treatment for hepatocellular carcinoma [EVOLVE-1 Trial], Hydrolyzed formula in susceptible infants does not reduce Diabetes-linked autoantibodies

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Tags: asthmaObstructive Sleep Apnea
Previous Post

Racial disparities in breast cancer survival associated with biologic tumor differences

Next Post

Extended, coordinated approaches were best to teach dermatologic diagnoses

RelatedReports

Microbe-rich environment associated with lower rates of asthma
Emergency

Impact of COVID-19 on pediatric asthma-related healthcare utilization in New York City

February 4, 2023
CPAP may not decrease cardiovascular events in sleep apnea
Endocrinology

Sodium-glucose cotransporter 2 inhibitors may reduce incidence of obstructive airway disease

February 2, 2023
Parents with poor sleep quality report sleep problems in kids
Chronic Disease

Intranasal corticosteroids no better than saline in treating pediatric sleep-disordered breathing

January 23, 2023
Evidence-based interventions for pediatric asthma successfully adapted for community health centers
Emergency

Emergency department crowding negative influences outcomes for adults presenting with asthma

December 27, 2022
Next Post
Four rash patterns common in adults with parvovirus infection

Extended, coordinated approaches were best to teach dermatologic diagnoses

Factor XI anti-sense oligonucleotide bests enoxaprin for venous thromboembolism in knee surgery

Factor XI anti-sense oligonucleotide bests enoxaprin for venous thromboembolism in knee surgery

Genetic mutation identified that underlies familial myelodysplastic syndrome [PreClinical]

Genetic mutation identified that underlies familial myelodysplastic syndrome [PreClinical]

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Metformin use may decrease risk of osteoarthritis development
  • Intensive blood pressure lowering by non-physician healthcare providers significantly reduces the risk of cardiovascular disease
  • Expectant management of patent ductus arteriosus noninferior to early ibuprofen use
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options